Armenian fermented milk product Choratan and its influence on gut microbiota in health and pathology

Zaruhi G. Kalikyan, V. Avagyan, A. Abrahamyan, L. Vardanyan, Alexander Selimyan, M. Avagyan
{"title":"Armenian fermented milk product Choratan and its influence on gut microbiota in health and pathology","authors":"Zaruhi G. Kalikyan, V. Avagyan, A. Abrahamyan, L. Vardanyan, Alexander Selimyan, M. Avagyan","doi":"10.31989/BCHD.V1I5.562","DOIUrl":null,"url":null,"abstract":"Background: Choratan is an ancient Armenian fermented milk product which was recreated as a food supplement by A. Selimyan with the use of innovative technologies. Choratan contains large amounts of active Lactobacillus acidophilus, amino acids, and other bioactive compounds. Material and method: The influence of Choratan on gut microflora was studied in the frame of grant projects through the financing of State Committee of Science of Armenia. One hundred forty-one randomly chosen patients were included in the study with their informed consent. The patients divided into groups by diseases: gastrointestinal, allergic, and diabetes mellitus II type. Healthy patients were included in the fourth group. Bacteriological examinations of faeces were performed on 120 patients before and after Choratan was prescribed with an average dosage of 4-6g a day for 8 weeks. Results: In all the groups, we observed improvements like the increase of normal microflora totally in 63.2%-68.3% and the decrease of conditionally pathogenic and pathogenic bacteria totally in 70.3%-100%. The mean amounts of all microorganisms were improved with statistically significant differences. 77.3% of patients noticed improvements in their conditions, which were more visible in healthy and allergic groups (87.1% and 82.4% respectively) and less impressive in patients with gastrointestinal diseases and diabetes (71.9% and 68.2% respectively).Conclusion: From the results, we can conclude Choratan has positive influence on gut microflora and common health statuses. However, these changes depend on the nature of the disease and initial degree of dysbiotic deviations. Accordingly, we encourage more detailed placebo-controlled investigations.Keywords: diseases; fermented foods; probiotics; bioactive food supplement, gut microflora; chronic diseases","PeriodicalId":93079,"journal":{"name":"Bioactive compounds in health and disease","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioactive compounds in health and disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31989/BCHD.V1I5.562","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Background: Choratan is an ancient Armenian fermented milk product which was recreated as a food supplement by A. Selimyan with the use of innovative technologies. Choratan contains large amounts of active Lactobacillus acidophilus, amino acids, and other bioactive compounds. Material and method: The influence of Choratan on gut microflora was studied in the frame of grant projects through the financing of State Committee of Science of Armenia. One hundred forty-one randomly chosen patients were included in the study with their informed consent. The patients divided into groups by diseases: gastrointestinal, allergic, and diabetes mellitus II type. Healthy patients were included in the fourth group. Bacteriological examinations of faeces were performed on 120 patients before and after Choratan was prescribed with an average dosage of 4-6g a day for 8 weeks. Results: In all the groups, we observed improvements like the increase of normal microflora totally in 63.2%-68.3% and the decrease of conditionally pathogenic and pathogenic bacteria totally in 70.3%-100%. The mean amounts of all microorganisms were improved with statistically significant differences. 77.3% of patients noticed improvements in their conditions, which were more visible in healthy and allergic groups (87.1% and 82.4% respectively) and less impressive in patients with gastrointestinal diseases and diabetes (71.9% and 68.2% respectively).Conclusion: From the results, we can conclude Choratan has positive influence on gut microflora and common health statuses. However, these changes depend on the nature of the disease and initial degree of dysbiotic deviations. Accordingly, we encourage more detailed placebo-controlled investigations.Keywords: diseases; fermented foods; probiotics; bioactive food supplement, gut microflora; chronic diseases
亚美尼亚发酵乳制品Choratan及其对健康和病理肠道菌群的影响
背景:Choratan是一种古老的亚美尼亚发酵乳制品,由a . Selimyan使用创新技术重新制作为食品补充剂。Choratan含有大量的活性嗜酸乳杆菌、氨基酸和其他生物活性化合物。材料和方法:在亚美尼亚国家科学委员会资助的资助项目框架内研究了Choratan对肠道微生物群的影响。141名随机选择的患者在知情同意的情况下被纳入研究。患者按疾病分为胃肠道型、过敏性型和糖尿病II型。健康患者为第四组。对120例患者在给药前后进行粪便细菌学检查,平均剂量为4-6g /天,连续8周。结果:各组正常菌群总数增加63.2% ~ 68.3%,条件性致病菌和致病菌总数减少70.3% ~ 100%。所有微生物的平均数量都有所提高,差异有统计学意义。77.3%的患者注意到他们的病情有所改善,这在健康和过敏组中更为明显(分别为87.1%和82.4%),而在胃肠道疾病和糖尿病患者中则不那么明显(分别为71.9%和68.2%)。结论:Choratan对肠道菌群和常见健康状况有积极影响。然而,这些变化取决于疾病的性质和最初的生态失调程度。因此,我们鼓励更详细的安慰剂对照研究。关键词:疾病;发酵食品;益生菌;生物活性食品补充剂,肠道菌群;慢性疾病
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.50
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信